−0.070CAD
−7.72 MCAD
5.07 MCAD
88.01 M
About RAMM PHARMA CORP.
Sector
CEO
Jackie Peter Burnett
Headquarters
Toronto
Website
Founded
1988
ISIN
CA75150G1046
FIGI
BBG00QS5KZ82
RAMM Pharma Corp. engages in the field of cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. It offers Epifractan and CannabiPiel. The company was founded in 1988 and is headquartered in Toronto, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of RAMM is 0.05 CAD — it has decreased by 7.69% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on CSE exchange RAMM PHARMA CORP. stocks are traded under the ticker RAMM.
Yes, you can track RAMM PHARMA CORP. financials in yearly and quarterly reports right on TradingView.
Like other stocks, RAMM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RAMM PHARMA CORP. stock right from TradingView charts — choose your broker and connect to your account.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RAMM PHARMA CORP. EBITDA is −5.50 M CAD, and current EBITDA margin is −113.14%. See more stats in RAMM PHARMA CORP. financial statements.